Cargando…

Immune response in breast cancer brain metastases and their microenvironment: the role of the PD-1/PD-L axis

BACKGROUND: A better understanding of immune response in breast cancer brain metastases (BCBM) may prompt new preventive and therapeutic strategies. METHODS: Immunohistochemical expression of stromal tumor-infiltrating lymphocytes (TILs: CD4, CD8, CTLA4), macrophage/microglial cells (CD68), programm...

Descripción completa

Detalles Bibliográficos
Autores principales:	Duchnowska, Renata, Pęksa, Rafał, Radecka, Barbara, Mandat, Tomasz, Trojanowski, Tomasz, Jarosz, Bożena, Czartoryska-Arłukowicz, Bogumiła, Olszewski, Wojciech P., Och, Waldemar, Kalinka-Warzocha, Ewa, Kozłowski, Wojciech, Kowalczyk, Anna, Loi, Sherene, Biernat, Wojciech, Jassem, Jacek
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4847231/ https://www.ncbi.nlm.nih.gov/pubmed/27117582 http://dx.doi.org/10.1186/s13058-016-0702-8

Ejemplares similares

Conversion of epidermal growth factor receptor 2 and hormone receptor expression in breast cancer metastases to the brain
por: Duchnowska, Renata, et al.
Publicado: (2012)

Pathway-level mutation analysis in primary high-grade serous ovarian cancer and matched brain metastases
por: Duchnowska, Renata, et al.
Publicado: (2022)

Predictive value of quantitative HER2, HER3 and p95HER2 levels in HER2-positive advanced breast cancer patients treated with lapatinib following progression on trastuzumab
por: Duchnowska, Renata, et al.
Publicado: (2017)

Tumor Budding Is an Independent Prognostic Factor in Pancreatic Adenocarcinoma and It Positively Correlates with PD-L1 Expression on Tumor Cells
por: Pęksa, Rafał, et al.
Publicado: (2022)

Predicting early brain metastases based on clinicopathological factors and gene expression analysis in advanced HER2-positive breast cancer patients
por: Duchnowska, Renata, et al.
Publicado: (2015)

Immunohistochemical prediction of lapatinib efficacy in advanced HER2-positive breast cancer patients
por: Duchnowska, Renata, et al.
Publicado: (2015)

PD-L1 expression on immune cells is a favorable prognostic factor for vulvar squamous cell carcinoma patients
por: Sznurkowski, Jacek J., et al.
Publicado: (2017)

Multicentre, Prospective Observational Study of Pegfilgrastim Primary Prophylaxis in Patients at High Risk of Febrile Neutropenia in Poland: PROFIL Study
por: Jurczak, Wojciech, et al.
Publicado: (2015)

Immunohistochemical Predictors of Bone Metastases in Breast Cancer Patients
por: Winczura, Piotr, et al.
Publicado: (2015)

The Usefulness of Prognostic Tools in Breast Cancer Patients with Brain Metastases
por: Kufel-Grabowska, Joanna, et al.
Publicado: (2022)

An open label phase II study evaluating first-line EGFR tyrosine kinase inhibitor erlotinib in non-small cell lung cancer patients with tumors showing high EGFR gene copy number
por: Szutowicz-Zielinska, Ewa, et al.
Publicado: (2016)

Immunohistochemical assays incorporating SP142 and 22C3 monoclonal antibodies for detection of PD-L1 expression in NSCLC patients with known status of EGFR and ALK genes
por: Krawczyk, Paweł, et al.
Publicado: (2017)

Combined Assessment of Immune Checkpoint Regulator VISTA on Tumor-Associated Immune Cells and Platelet-to-Lymphocyte Ratio Identifies Advanced Germ Cell Tumors with Higher Risk of Unfavorable Outcomes
por: Pęksa, Rafał, et al.
Publicado: (2021)

Increased MET and HGF gene copy numbers are associated with trastuzumab failure in HER2-positive metastatic breast cancer
por: Minuti, G, et al.
Publicado: (2012)

Efficacy and safety of ipilimumab therapy in patients with metastatic melanoma: a retrospective multicenter analysis
por: Wiater, Katarzyna, et al.
Publicado: (2013)

The efficacy of EGFR gene mutation testing in various samples from non-small cell lung cancer patients: a multicenter retrospective study
por: Krawczyk, Paweł, et al.
Publicado: (2014)

PD-1 and PD-L1 Expression Levels as a Potential Biomarker of Chronic Rhinosinusitis and Head and Neck Cancers
por: Malinowska, Katarzyna, et al.
Publicado: (2023)

The knowledge of public access to defibrillation in selected cities in Poland
por: Kozłowski, Dariusz, et al.
Publicado: (2013)

Childhood longitudinal melanonychia: case series from Poland
por: Sobjanek, Michał, et al.
Publicado: (2019)

Polymorphisms in TS, MTHFR and ERCC1 genes as predictive markers in first-line platinum and pemetrexed therapy in NSCLC patients
por: Krawczyk, Paweł, et al.
Publicado: (2014)

The PD-1/PD-L1 Inhibitory Pathway is Altered in Primary Glomerulonephritides
por: Grywalska, Ewelina, et al.
Publicado: (2017)

Immuno-PET Imaging of Tumour PD-L1 Expression in Glioblastoma
por: Sharma, Gitanjali, et al.
Publicado: (2023)

PD-L1-Positive High-Grade Triple-Negative Breast Cancer Patients Respond Better to Standard Neoadjuvant Treatment—A Retrospective Study of PD-L1 Expression in Relation to Different Clinicopathological Parameters
por: Stanowska, Olga, et al.
Publicado: (2022)

Castleman’s disease mimicking lymph node metastases in a young woman with laryngeal cancer
por: Serkies, Krystyna, et al.
Publicado: (2016)

Immune checkpoint receptor VISTA on immune cells is associated with expression of T-cell exhaustion marker TOX and worse prognosis in renal cell carcinoma with venous tumor thrombus
por: Zapała, Łukasz, et al.
Publicado: (2022)

Transparent to Black Electrochromism—The “Holy Grail” of Organic Optoelectronics
por: Jarosz, Tomasz, et al.
Publicado: (2019)

A Comparison of Hydrogen Storage in Pt, Pd and Pt/Pd Alloys Loaded Disordered Mesoporous Hollow Carbon Spheres
por: Baca, Martyna, et al.
Publicado: (2018)

Expression of HTRA Genes and Its Association with Microsatellite Instability and Survival of Patients with Colorectal Cancer
por: Zurawa-Janicka, Dorota, et al.
Publicado: (2020)

Tandem Pd-Catalyzed Cyclization/Coupling of Non-Terminal Acetylenic Activated Methylenes with (Hetero)Aryl Bromides †
por: Błocka, Aleksandra, et al.
Publicado: (2022)

Calorimetric Studies of Magnesium-Rich Mg-Pd Alloys
por: Dębski, Adam, et al.
Publicado: (2021)

Expression of Female Sex Hormone Receptors, Connective Tissue Growth Factor and HER2 in Gallbladder Cancer
por: Hryciuk, Beata, et al.
Publicado: (2020)

Prevalence of NRAS, PTEN and AKT1 gene mutations in the central nervous system metastases of non-small cell lung cancer
por: Nicoś, Marcin, et al.
Publicado: (2017)

Beyond PD-L1 Markers for Lung Cancer Immunotherapy
por: Wojas-Krawczyk, Kamila, et al.
Publicado: (2019)

Noninvasive Imaging of Immune Checkpoint Ligand PD-L1 in Tumors and Metastases for Guiding Immunotherapy
por: Chatterjee, Samit, et al.
Publicado: (2017)

Prostate Cancer and Its Mimics—A Pictorial Review
por: Żurowska, Anna, et al.
Publicado: (2023)

The Role of BCL-2 and PD-1/PD-L1 Pathway in Pathogenesis of Myelodysplastic Syndromes
por: Kuszczak, Bartłomiej, et al.
Publicado: (2023)

Effect of Scanning and Support Strategies on Relative Density of SLM-ed H13 Steel in Relation to Specimen Size
por: Kurzynowski, Tomasz, et al.
Publicado: (2019)

Pd-Catalyzed α-Arylation of α,α-Difluoroketones with Aryl Bromides and Chlorides. A Route to Difluoromethylarenes
por: Ge, Shaozhong, et al.
Publicado: (2014)

Bioelectrical function and structural assessment of the retina in patients with early stages of Parkinson’s disease (PD)
por: Nowacka, Barbara, et al.
Publicado: (2015)

Genomic Profiling Identifies Putative Pathogenic Alterations in NSCLC Brain Metastases
por: Nicoś, Marcin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_n3fpgdkpugmskop3vj21sk44sk